Concepedia

Kunihiro Tsuji

KT

40

Publications

2.1K

Citations

23

H-Index

1985

Active since

Affiliations

Ishikawa Prefectural Central Hospital(Current)

National Cancer Center Hospital East

Aichi Cancer Center

Japanese Foundation For Cancer Research

Kanagawa Cancer Center

Kunihiro Tsuji is an author at Ishikawa Prefectural Central Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1985–2025

40

Publications

40

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang, Li‐Tzong Chen, Min‐Hee Ryu et al. · The Lancet Oncology · 2022 · 712 citations · Full text

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

Masato Ozaka, Hiroshi Ishii, Tosiya Sato et al. · Cancer Chemotherapy and Pharmacology · 2018 · 155 citations

, , +7

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 124 citations · Full text

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

Narikazu Boku, M.-H. Ryu, D-Y. Oh et al. · Annals of Oncology · 2020 · 123 citations

, , +8

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System

Chigusa Morizane, Nozomu Machida, Yoshitaka Honma et al. · JAMA Oncology · 2022 · 85 citations · Full text

Rows per page

1–5 of 40